The Hsp90 inhibitor ganetespib overcomes EGFR-based intratumoral heterogeneity to block glioma proliferation

被引：0
|
作者：
Driscoll, James J. [1 ]
Narayanan, Nitin S. [1 ]
Jagannathan, Sajjeev [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-LB-140
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-140
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Heat shock protein 90 (Hsp90) inhibitor STA-9090 (Ganetespib) ameliorates inflammation in a mouse model of atopic dermatitis
    Krzysztof Sitko
    Michał Starke
    Stefan Tukaj
    Cell Stress and Chaperones, 2023, 28 : 935 - 942
  • [42] PRECLINICAL EVALUATION OF NXD30001, A NOVEL HSP90 INHIBITOR, FOR EFFICACY IN GLIOMA
    Chen, Ruihong
    Yu, Jin-Chen
    Liu, Chian
    Jaffer, Zahara M.
    Chabala, John C.
    Winssinger, Nicolas
    Rubenstein, Allan E.
    NEURO-ONCOLOGY, 2010, 12 : 90 - 90
  • [43] Heat shock protein 90 (Hsp90) inhibitor STA-9090 (Ganetespib) ameliorates inflammation in a mouse model of atopic dermatitis
    Sitko, Krzysztof
    Starke, Michal
    Tukaj, Stefan
    CELL STRESS & CHAPERONES, 2023, 28 (06): : 935 - 942
  • [44] Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans (vol 12, 680382, 2021)
    Yuan, Rui
    Tu, Jie
    Sheng, Chunquan
    Chen, Xi
    Liu, Na
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [45] Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
    Shah, Shalin
    Luke, Jason J.
    Jacene, Heather A.
    Chen, Tianqi
    Giobbie-Hurder, Anita
    Ibrahim, Nageatte
    Buchbinder, Elizabeth L.
    McDermott, David F.
    Flaherty, Keith T.
    Sullivan, Ryan J.
    Lawrence, Donald P.
    Ott, Patrick A.
    Hodi, F. Stephen
    MELANOMA RESEARCH, 2018, 28 (06) : 605 - 610
  • [46] The HSP90 inhibitor ganetespib potentiates effect of ionizing radiation in human non-small cell lung cancer
    Casal, Roberto Gomez
    Bhattacharya, Chitralekha
    Epperly, Michael
    Socinski, Mark
    Levina, Vera
    CANCER RESEARCH, 2014, 74 (19)
  • [47] Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer
    London, Cheryl A.
    Bear, Misty D.
    McCleese, Jennifer
    Foley, Kevin P.
    Paalangara, Reji
    Inoue, Takayo
    Ying, Weiwen
    Barsoum, James
    PLOS ONE, 2011, 6 (11):
  • [48] Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling
    Proia, David A.
    Foley, Kevin P.
    Korbut, Tim
    Sang, Jim
    Smith, Don
    Bates, Richard C.
    Liu, Yuan
    Rosenberg, Alex F.
    Zhou, Dan
    Koya, Keizo
    Barsoum, James
    Blackman, Ronald K.
    PLOS ONE, 2011, 6 (04):
  • [49] The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
    Smith, Donald L.
    Acquaviva, Jaime
    Sequeira, Manuel
    Jimenez, John-Paul
    Zhang, Chaohua
    Sang, Jim
    Bates, Richard C.
    Proia, David A.
    TARGETED ONCOLOGY, 2015, 10 (02) : 235 - 245
  • [50] The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
    Donald L. Smith
    Jaime Acquaviva
    Manuel Sequeira
    John-Paul Jimenez
    Chaohua Zhang
    Jim Sang
    Richard C. Bates
    David A. Proia
    Targeted Oncology, 2015, 10 : 235 - 245
12345